Navigation Links
Eric Setzer Appointed CFO of Avista Pharma Solutions

DURHAM, N.C., Feb. 8, 2016 /PRNewswire/ -- Avista Pharma Solutions ("Avista Pharma") announced today that it has appointed Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer is a finance and operations executive with over twenty years of experience in various roles within growing technology and life science companies. Prior to joining Avista Pharma, he served as the Executive Director of Finance at INC Research, a publicly traded clinical research organization in Raleigh, NC. Previously, Mr. Setzer served as CFO of Expression Analysis, a genomics service provider located in Research Triangle Park, NC which was sold to Quintiles in 2012. Mr. Setzer was also CFO of three separate venture capital-funded companies in the health care technology sector, and he was the controller of TriPath Imaging, a publicly traded cervical cytology screening company.  Mr. Setzer began his career in public accounting, working for Price Waterhouse in Rochester, New York, and the Entrepreneurial Services Group of Ernst & Young in Raleigh, North Carolina.

"We are delighted to have Eric join our dynamic team at a time when Avista Pharma is expanding our contract services," said Mr. Patrick Walsh, Chief Executive Officer (CEO) of Avista Pharma. "We continue to advance an aggressive growth and acquisition strategy and Eric's experience and leadership will add value to the company."

"I am excited to join Avista Pharma at such a key stage of growth," said Mr. Setzer. "Avista Pharma is already a top-tier company in the CDMO sector, and I look forward to being part of a dynamic growth opportunity."

Mr. Setzer received his MBA from Duke University, has an undergraduate degree in Accounting and Economics from Oswego State University and is a licensed Certified Public Accountant.

About Avista Pharma Solutions:

Avista Pharma Solutions, a portfolio company of Ampersand Capital Partners, is a contract testing, development and manufacturing organization encompassing over 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, MA, Durham, NC, and Longmont, CO), providing pharmaceutical, animal health and medical device clients with a broad suite of scientifically-differentiated services ranging from early drug development to drug product manufacturing. For more information on Avista Pharma Solutions, please see

About Ampersand Capital Partners:

Ampersand is a middle market private equity firm with a focus on growth equity investments in the healthcare sector. Over the past two decades, Ampersand has managed more than $1 billion in private equity partnerships. Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Additional information about Ampersand is available at

Avista Pharma Solutions
Jeff A. Parrott, Ph.D.
Corporate Communications

Logo -

SOURCE Avista Pharma Solutions
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices Founder Marco Chacon Appointed by Governor Hogan to Maryland Life Sciences Advisory Board
2. Gary Zieziula Appointed President and Managing Director of EMD Serono
3. Kevin Smith Appointed Chief Commercial Officer (CCO) of Sensium Healthcare
4. Andreas Knaack Appointed President of Invetech
5. EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
6. Georgia Erbez Appointed Chief Financial Officer Of Asterias Biotherapeutics
7. Former Deputy Attorney General Appointed To Advise Valeants Ad Hoc Committee
8. Martha Marsh Appointed To Edwards Lifesciences Board Of Directors
9. Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
10. Janet S. Vergis Appointed to Impax Laboratories Board of Directors
11. Shawn Cline Tomasello and Benjamin Wolin appointed to Diplomat Board of Directors
Post Your Comments:
(Date:7/1/2020)... ... July 01, 2020 , ... Stratodesk ... NoTouch OS is available on NComputing devices. Thanks to fantastic new growth and ... have formed a new partnership that will make the full Stratodesk NoTouch OS ...
(Date:6/25/2020)... ... June 25, 2020 , ... ... UK to build a distributed ledger platform to store COVID-19 related certificates to ... will provide a fully functioning prototype for publishing, sharing and verifying a wide ...
(Date:6/25/2020)... ... June 25, 2020 , ... ... Oregon , , “Eyes are our number one sensory ... Radio & Apple iTunes. “Being able to see clearly is being able to ...
Breaking Medicine Technology:
(Date:6/28/2020)... ... June 28, 2020 , ... World Allergy Organization (WAO), serving ... from June 28 to July 4, 2020, to the importance of continued allergy ... “coronavirus disease 2019”, is a disease spreading around the world caused by infection ...
(Date:6/24/2020)... ... 2020 , ... At Allerio we have chosen to do things differently. At ... knew it had to be portable, it had to be reliable, it had to ... , We are proud to announce that Allerio has passed all FCC and carrier ...
(Date:6/24/2020)... ... 2020 , ... Skyroam , the developer of patented virtual SIM (vSIM) ... leading provider of enterprise software for testing laboratories, in which its Skyroam Solis Lite ... Disease Surveillance Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... Rritual ... Dr. Mike Hart has been named as the President of North America’s leading ... in plant based therapy, including owning and operating his own family medicine clinic in ...
(Date:6/23/2020)... (PRWEB) , ... June 22, 2020 , ... A June ... a face mask. In light of the country slowly opening back up while adjusting ... available products for areas of the face that aren’t covered such as eyelids, lashes, ...
Breaking Medicine News(10 mins):